<unk>  is a vaccine used to treat cancer, specifically non-small-cell lung carcinoma (NSCLC).<unk>  is composed of recombinant human epidermal growth factor <unk>  conjugated to a protein carrier. The vaccine was developed by the Center of Molecular Immunology, Havana, Cuba. There are agreements in place to test it in the United States, Japan, and some European countries. It is currently available in Cuba, Colombia, Bosnia and Herzegovina, Peru and Paraguay. In October 2015 Serbia's Institute of Virology, Vaccines and Sera (AKA Torlak Institute) signed a memorandum for use in 30 patients as part of a study.<unk>  is relatively cheap to produce and store, and has low toxicity. Side effects of the vaccine appear to be mild, and include chills, fever, and feeling sick.
CimaVax-EGF
Biocitech
ScotSTAR
Alloplant
Poly-MVA
Elastix 
Trafermin
Metab-L